# Whizdotai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/whizdotai

- Industry: Software
- Headquarters: Somerset, US
- Website: www.whiz.ai
- Total disclosed funding: $20M
- Latest round: Series A (Sep 26, 2022)
- Investors on record: 6

## About

Whizdotai, Inc. delivers advanced analytics solutions for the life sciences sector, transforming complex data into actionable insights through proprietary technologies and domain-specific models.Founded in 2017 and headquartered in Somerset, US, Whizdotai, Inc. specializes in analytics for the pharmaceutical and healthcare industries. The company has completed four deals, with its most recent funding round occurring on September 26, 2022. Whizdotai raised USD 6.00 mn in a Series A round led by Cencora, Inc., Healthy Ventures, Shanda Capital, and Vertical Venture Partners. The current valuation of the company is USD 44.017 mn. The co-founders, Amitabh Patil and Rohit Vashisht, have a history of entrepreneurial success, with Vashisht currently serving as CEO.WhizAI specializes in advanced analytics solutions tailored specifically for the life sciences sector, with a focus on transforming data into actionable insights. At the core of their offerings is a proprietary intent-ready Natural Language Processing (NLP) engine combined with domain-tuned Large Language Models (LLM) designed to deliver precise, contextual insights across various platforms such as Veeva, Microsoft Teams, and Salesforce. These tools support a range of use cases, including sales performance tracking, clinical site efficiency optimization, market access analysis, and enhanced patient experience analytics. WhizAI's solutions enable clients—primarily global pharmaceutical companies, clinical research organizations, and healthcare providers—to make informed, data-driven decisions in real-time, thereby improving operational efficiency and strategic outcomes. The company serves a broad client base across North America, Europe, and Asia, capitalizing on the growing demand for innovative analytics solutions in these key geographical markets.WhizAI generates revenue through a subscription-based model, allowing clients to access its suite of analytics tools and support services. The business transactions typically involve annual contracts and tiered pricing structures based on the scale and specific needs of the client organization. Clients, primarily from the pharmaceutical and healthcare sectors, utilize these services to unlock insights from vast data sets, enhancing their decision-making processes. The flagship products, including the proprietary NLP engine and domain-tuned LLM, are integral to the platform's offering, driving consistent engagement from users who rely on real-time analytics for various operational needs. This established transaction framework fosters long-term partnerships, focusing on delivering continued value to clients in a rapidly evolving market.In September 2022, Whizdotai, Inc. raised USD 6 mn in Series A funding, which will be utilized to further develop its market. The company plans to launch new products aimed at enhancing its analytics capabilities and is targeting expansion into additional markets across Asia and Europe by 2024. This funding will support these initiatives, driving the development of new technologies and market penetration strategies.

## Funding rounds

- Series A, Sep 26, 2022, $6M — Cencora, Inc., Shanda Capital, Vertical Venture Partners, Healthy Ventures
- Series A, Dec 14, 2021, $8M — Vertical Venture Partners
- Seed, Jun 8, 2020, $5.8M — Firebolt Ventures, Healthy Ventures, Bling Capital

## Investors

- Firebolt Ventures (https://capitalatlas.ai/funds/firebolt-ventures) — Seed
- Healthy Ventures (https://capitalatlas.ai/funds/healthy-ventures) — Seed, Series A
- Bling Capital (https://capitalatlas.ai/funds/bling-capital) — Seed
- Vertical Venture Partners (https://capitalatlas.ai/funds/vertical-venture-partners) — Series A
- Cencora, Inc. — Series A
- Shanda Capital — Series A